Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
About this item
Full title
Author / Creator
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Journal title
Language
English
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine
Subjects
More information
Scope and Contents
Contents
In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab [a monoclonal antibody targeting epidermal growth factor receptor (EGFR)] has been shown to improve overall survival when combined with radiotherapy in the locally advanced setting or with chemotherapy in first-line recurrent and/or metastatic (R/M) setting, respectively. Whi...
Alternative Titles
Full title
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_eba8405028cf475c9057a1a41cb20489
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eba8405028cf475c9057a1a41cb20489
Other Identifiers
ISSN
2095-3941
DOI
10.20892/j.issn.2095-3941.2019.0153
